Developed with US respiratory specialist firm Innoviva, the drug (known as Breo Ellipta in the US) is GSK’s follow up to its respiratory blockbuster Advair/Seretide, but won’t come close to ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...

In this article, we are going to look at where GoodRx Holdings, Inc. (NASDAQ:GDRX) stands against other best NASDAQ penny stocks to buy right now. The NASDAQ Stock Market is home to some of the ...